The global sustainable pharmaceutical packaging market was valued at USD 71.80 billion in 2022 and is expected to grow at a CAGR of 16.15% during the forecast period. One of the main drivers of development for the Sustainable Pharmaceutical Packaging industry is the enormous growth of the pharmaceutical sector. Scientific and technological advancements have caused the pharmaceutical industry to grow quickly in recent years, and it is expected that this trend will continue over the projection period, especially in developing countries like China, India, and Brazil. The biggest pharmaceutical market in the world was in the United States.
Know more about this report: Request for sample pages
Among the major variables influencing the U.S. market are the size of the healthcare system, the high per capita income, and the sizeable investments made in drug development in the nation. Furthermore, lucrative possibilities for Sustainable Pharmaceutical Packaging are anticipated in the upcoming years due to the expanding significance of generic medications and availability to better healthcare services. The 21st Century Cures Act (Cures Act), which aims to hasten the creation of medical products, was signed into law in the United States on December 13, 2016. The legislation is anticipated to spur fresh product developments in the pharmaceutical sector. The demand for medicinal packaging in the US is anticipated to increase as a result.
The development of medicine and bioscience is what primarily drives the pharmaceutical business. In addition, the pharmaceutical business contributes significantly to the European economy as one of the continent's most successful high-tech industries. The pharmaceutical industry is undergoing a significant transformation, and over the past few years, there has been a marked increase in attention paid to the creation of biopharmaceutical drugs. Few biotechnology-based drug therapies are launched as lyophilized or dry powder dosage forms because they are unstable in liquid form. Lyophilized medications require specialised packaging to work at their best, opening up new market opportunities for packaging manufacturers.
The most common medication delivery methods for pharmaceuticals are tablets, capsules, liquids, and powders. They are packaged in a variety of packing formats, such as rigid bottles, standup pouches, flat pouches, sachets, and blister cases. In order to improve the functionality and safety of their packaging, packaging companies are increasingly concentrating on the incorporation of dispensing mechanisms, administration aids, sustainable materials, tamper-evident properties, and counterfeiting measures.
The Covid-19 epidemic was beneficial to the sector. Increased demand for packing was made possible by investments in drug discovery as well as increased output and usage of pharmaceuticals. Additionally, the disease outbreak sparked concern over the virus's ability to survive on packing surfaces, spurring an increase in the creation of high-performance and sustainable packing.
To increase the sustainability of packaging, businesses are primarily concentrating on the use of post-consumer recycled (PCR) material and creating packaging from compostable material. Leading provider of Sustainable Pharmaceutical Packaging, Gerresheimer AG, has been selling glass boxes made of PCR glass for a while. Additionally, the business sells jugs made of R-PET and BIO-PET (resins made from sugarcane plants). In the upcoming years, it is anticipated that the trend towards sustainable packaging will accelerate considerably.
Growth Drivers
Over the years, the global healthcare and pharmaceutical industries have experienced tremendous development. In the near future, it is anticipated that the market will expand more quickly due to factors including the expanding population, rising life expectancy rate, widespread adoption of a healthy lifestyle, and growing customer knowledge of an effective healthcare system.
During the forecast period, the sustainable pharmaceutical packaging market is likely to expand at a faster rate due to increasing government initiatives, increased investment in drug discovery, and technological advancement. For instance, the Honeywell India Technology Center (HITC), a global packaging lab in Gurgaon, Haryana (India), creates cutting-edge technologies for Sustainable Pharmaceutical Packaging and supports its regional partners with the necessary technical help.
The market is primarily segmented based on material, product type, end-use, and region.
By Material |
By Product |
By End-use |
By Region |
|
|
|
|
Know more about this report: Request for sample pages
The sector with the largest income share in 2022 was plastics & polymers. Pharmaceutical vials, bottles, closures, needles, pouches, sachets, cartridges, tubes, and blister packs are frequently made from a variety of plastic resins, such as PE, PET, PP, PVC, PS, and bioplastic. The plastic and polymers material segment's biggest revenue share in 2020 belonged to polypropylene (PP), which offers a range of advantageous mechanical, physical, electrical, and thermal characteristics.
In 2022, the primary segment held the lion's portion of the market. Primary packing, like bottles, tubes, or blister packs, comes into direct touch with the medication and encloses it to shield it from contamination. Additionally, it frequently handles the dosing and dispensing of medication ingredients. In order to help the elderly population with drug dosage, packaging firms are concentrating on easy-to-open closures and the incorporation of dispensing systems that deliver the right dose at the right moment.
The crucial end-use sector of pharmaceutical manufacturing, which held the largest share in 2022, is anticipated to experience rapid development from 2023 to 2030. The rising desire for medications is to blame for this. According to the World Health Organization (WHO), the percentage of people over 60 in the world's population will nearly double from 12% to 22% between 2015 and 2050. The ageing population needs more medical care, which supports the industry that makes pharmaceuticals. This will probably lead to an increase in demand for pharmaceutical containers.
In 2022, North America dominated the market. The region's largest end-use sector was pharmaceutical manufacturing, which encompasses in-house production. Over the course of the forecast period, the existence of numerous producers of pharmaceutical plastic bottles in the nation, including AptarGroup Inc., Gerresheimer AG, Amcor Ltd., and Berry Plastics Group, Inc., is likely to have a positive effect on the demand for these bottles.
From 2023 to 20302, Asia Pacific is anticipated to experience the highest CAGR of more than 12%. Over the forecast period, it is anticipated that rising disposable income levels and rising health consciousness among consumers in the Asia Pacific, particularly in developing nations like China and India, will boost the development of the pharmaceutical industry and increase demand for its packaging.
Among the top companies competing in the international sustainable pharmaceutical packaging market are Amcor Plc, Aptargroup, Inc., Becton, Dickinson and Company, Berry Global Inc., Catalent, Inc., CCL Industries, Inc., Comar, LLC, Drug Plastics Group, Gerresheimer AG, International Paper, Nipro Corporation, Owens Illinois Inc., Schott AG, Silgan Holdings Inc., Stevanato Group, Vetter Pharma International, West Pharmaceutical Services, Inc.
Report Attributes |
Details |
Market size value in 2023 |
USD 82.02 billion |
Revenue forecast in 2032 |
USD 315.59 billion |
CAGR |
16.15% from 2023 - 2032 |
Base year |
2021 |
Historical data |
2019 - 2022 |
Forecast period |
2023 - 2032 |
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2032 |
Segments covered |
By Material, By Product Type, By End-use, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Key companies |
Amcor Plc, Aptargroup, Inc., Becton, Dickinson and Company, Berry Global Inc., Catalent, Inc., CCL Industries, Inc., Comar, LLC, Drug Plastics Group, Gerresheimer AG, International Paper, Nipro Corporation, Owens Illinois Inc., Schott AG, Silgan Holdings Inc., Stevanato Group, Vetter Pharma International, West Pharmaceutical Services, Inc |
The sustainable pharmaceutical packaging market report covering key segments are material, product type, end-use, and region.
Sustainable Pharmaceutical Packaging Market Size Worth $315.59 Billion by 2032.
The global sustainable pharmaceutical packaging market expected to grow at a CAGR of 16.15% during the forecast period.
North America is leading the global market.
key driving factors in sustainable pharmaceutical packaging market are growing customer knowledge of an effective healthcare system.